Related Experiment Videos
Using data mining techniques to explore physicians' therapeutic decisions when clinical guidelines do not provide
Massoud Toussi1, Jean-Baptiste Lamy, Philippe Le Toumelin
1UFR SMBH, Université Paris, Bobigny, France. massoudtoussi@gmail.com
BMC Medical Informatics and Decision Making
|June 12, 2009
Summary
This study uses data mining to identify knowledge gaps in clinical guidelines for type 2 diabetes management. The approach learns from physician prescriptions to suggest new recommendations, improving guideline completeness.
Area of Science:
- Medical Informatics
- Clinical Decision Support
- Data Mining in Healthcare
Background:
- Clinical guidelines are essential for evidence-based practice but often have knowledge gaps.
- Unaddressed clinical situations limit comprehensive patient care.
- A novel approach is proposed to identify and fill these gaps using data mining.
Purpose of the Study:
- To develop and demonstrate a data mining method for identifying knowledge gaps in clinical guidelines.
- To explore physicians' therapeutic decisions to generate evidence-based recommendations.
- To fill identified knowledge gaps in type 2 diabetes management guidelines.
Main Methods:
- Analysis of French national type 2 diabetes guidelines to identify gaps.
- Extraction of patient records for uncovered clinical conditions from a hospital database.
- Application of C5.0 decision-tree learning to physician prescriptions.
- Development of decision-trees for treatment type, class, INN, and dose.
- Comparison of learned rules with updated guideline recommendations.
Main Results:
- 27 rules were extracted from 463 patient records.
- Rules were identified for treatment type (11) and pharmaco-therapeutic class (13).
- Limited rules for drug name and dose due to insufficient patient data.
- Extracted rules demonstrated similarity to newer guideline versions.
Conclusions:
- The method effectively complements guideline recommendations with practice-based knowledge.
- It serves as a valuable tool for guideline development and evaluation.
- Physician practice, as reflected in prescriptions, can sometimes precede guideline recommendations.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...